NY A06425

Health insurance plans must cover at least two medically necessary epinephrine auto-injector devices for emergency treatment of life-threatening allergic reactions.

Out-of-pocket costs for covered epinephrine auto-injector devices are capped at $100 annually, regardless of deductibles, copayments, coinsurance, or other cost-sharing requirements.

Coverage requirements apply to individual policies, group policies, blanket policies, and plans issued by medical expense indemnity corporations, hospital service corporations, and health service corporations that provide major medical or comprehensive coverage.

Health savings account-qualified high deductible health plans must provide coverage after the enrollee satisfies the minimum deductible, except preventive care epinephrine auto-injectors are covered before the deductible is met.

The act takes effect January 1, 2026 and applies to all policies issued, renewed, modified, altered, or amended on or after that date.